SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-039910
Filing Date
2011-04-27
Accepted
2011-04-27 13:02:46
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a58878e10vq.htm 10-Q 377149
2 EX-31.1 a58878exv31w1.htm EX-31.1 6401
3 EX-31.2 a58878exv31w2.htm EX-31.2 6738
4 EX-32.1 a58878exv32w1.htm EX-32.1 3985
5 EX-32.2 a58878exv32w2.htm EX-32.2 4004
  Complete submission text file 0000950123-11-039910.txt   4602800

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT wpi-20110331.xml EX-101.INS 520882
7 EX-101 SCHEMA DOCUMENT wpi-20110331.xsd EX-101.SCH 44672
8 EX-101 CALCULATION LINKBASE DOCUMENT wpi-20110331_cal.xml EX-101.CAL 56480
9 EX-101 LABELS LINKBASE DOCUMENT wpi-20110331_lab.xml EX-101.LAB 351652
10 EX-101 PRESENTATION LINKBASE DOCUMENT wpi-20110331_pre.xml EX-101.PRE 219931
11 EX-101 DEFINITION LINKBASE DOCUMENT wpi-20110331_def.xml EX-101.DEF 100665
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

IRS No.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 11782738
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1